Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07269262 · ClinicalTrials.gov registry record · NA
SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
A NA study of Interstitial Lung Disease and Progressive Pulmonary Fibrosis, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT07269262 is a NA study of Interstitial Lung Disease and Progressive Pulmonary Fibrosis that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 170 participants, below the 562-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07269262, a NA study of Interstitial Lung Disease and Progressive Pulmonary Fibrosis, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care intervention for patients with Progressive Pulmonary Fibrosis (PPF) and their caregivers. The intervention includes a 9-week digital application guided by a nurse interventionist and quarterly virtual support groups over one year. Participants will be recruited from rural South Carolina and urban New York City. The study compares SUPPORT-T to Enhanced Usual Care and aims to inform a future multi-site trial.
Conditions Studied
Interventions
- OTHER SUPPORT-T Educational Intervention
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2026-01-13 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07269262
The ClinicalTrials.gov registry entry for NCT07269262 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 562-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (70% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Interstitial Lung Disease appearing as the primary indexed condition, and to 1 intervention - of which SUPPORT-T Educational Intervention is the first listed.
NCT07269262 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT07269262 about?
NCT07269262 is a clinical study titled "SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers". This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care intervention for patients with Progressive Pulmonary Fibrosis (PPF) and their caregivers. The intervention includes a 9-week digital application guid...
What is the current status of trial NCT07269262?
This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2026-01-13. Estimated completion is 2027-10-01.
What conditions does trial NCT07269262 study?
This clinical trial studies the following conditions: Interstitial Lung Disease, Progressive Pulmonary Fibrosis.
What interventions are being tested in trial NCT07269262?
The interventions under investigation include: SUPPORT-T Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT07269262?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07269262 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Lung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
-
Palliative Care Planner (PCplanner)
COMPLETED · NA
-
Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD)
COMPLETED · NA
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
RECRUITING · Phase 2
-
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RECRUITING · Phase 3
Explore more on PlainTrial
Interstitial Lung Disease
All registered trials for this condition
Progressive Pulmonary Fibrosis
All registered trials for this condition
South Carolina
All trials with a study site in South Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.